Metric Finance
LearnFAQ
LearnFAQ

Learn / AZN

NYSE: AZN

Astrazeneca PLC (AZN) stock, explained like you're 5

Astrazeneca PLC trades on the New York Stock Exchange under the ticker AZN. It is a mega cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 246.9 billion dollars.

Ticker
AZN
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mega cap, about 246.9 billion dollars

Is Astrazeneca PLC a small, medium or large cap company?

Yes. Astrazeneca PLC is a large cap stock, and an extra big one: it is a mega cap, worth more than 200 billion dollars. Its market cap, which is the total value of all its shares, is about 246.9 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Astrazeneca PLC makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves AZN stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Astrazeneca (AZN) Rises Higher Than Market: Key Facts (Yahoo Finance)
  • Why AstraZeneca (AZN) Stock Is Up Today (Quiver Quantitative)
  • AstraZeneca PLC Stock Gains Favor As Oncology Deals Mount (timothysykes.com)
  • AstraZeneca inks AI drug discovery deal with insitro (AZN:NYSE) (Seeking Alpha)
  • AstraZeneca PLC Stock (AZN) Moved Up by 3.81% on Oct 14: A Full Analysis (TradingKey)

Follow AZN in your daily brief

Each trading day at 5 PM ET we post what happened to Astrazeneca PLC and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow AZN

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Astrazeneca PLC stock

What does Astrazeneca PLC do?

Astrazeneca PLC trades on the New York Stock Exchange under the ticker AZN. It is a mega cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 246.9 billion dollars.

What is the ticker symbol for Astrazeneca PLC?

Astrazeneca PLC trades under the ticker AZN on the New York Stock Exchange.

What is Astrazeneca PLC's market cap?

Astrazeneca PLC is a mega cap stock with a market cap of about 246.9 billion dollars.

How does Astrazeneca PLC make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves AZN stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow AZN stock every day?

Add AZN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow AZN daily

A free brief on Astrazeneca PLC and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma
  • SNY · Sanofi

Similar stocks

  • NVSNovartis AG
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma
  • SNYSanofi

Compare AZN: AZN vs NVS, AZN vs NVO, AZN vs VRTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed